Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × trofosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrence 1 Medulloblastoma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Temozolomide 28 Cyclophosphamide 28 Filgrastim 24 Etoposide 22 Carboplatin 21 Vincristine 17 Cisplatin 17 Radiotherapy 16 Magnetic Resonance Spectroscopy 15 Thiotepa 13 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 9 Specimen Handling 8 Methotrexate 8 Lomustine 8 Radiation 7 etoposide phosphate 6 X-Rays 6 Topotecan 6 Phantoms, Imaging 6 Biopsy 6 Platinum 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Bevacizumab 5 1,2-diaminocyclohexaneplatinum II citrate 5 sonidegib 4 sargramostim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡